Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.9B | 6.1B | 5.3B | 5.1B |
Cost of revenue | 3.2B | 3.3B | 2.9B | 2.7B |
Gross profit | 2.8B | 2.7B | 2.4B | 2.4B |
Operating expense | ||||
Research & development | 551M | 512M | 504M | 460M |
Selling general and admin | 854M | 890M | 871M | 729M |
Other operating expenses | — | — | — | — |
Operating income | 763M | 820M | 557M | 726M |
Non operating interest income | ||||
Income | 37M | 41M | 43M | 39M |
Expense | 39M | 48M | 40M | 39M |
Other income expense | -55M | -50M | -40M | -58M |
Pretax income | 706M | 763M | 520M | 668M |
Tax provision | 212M | 124M | 123M | 137M |
Net income | 494M | 639M | 397M | 531M |
Basic EPS | 9.7 | 12.6 | 7.8 | 10.5 |
Diluted EPS | 9.7 | 12.6 | 7.8 | 10.5 |
Basic average shares | 56.9M | 56.9M | 56.9M | 56.9M |
Diluted average shares | 56.9M | 56.9M | 56.9M | 56.9M |
EBITDA | 972M | 1.0B | 757M | 919M |
Net income from continuing op. | 494M | 639M | 397M | 531M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | 0 | 0 | — |